Skip to main content
Search

Swati Jaiman*, Dr. Tara Chand, Ashish Jain

1 related articles

Subscribe to updates
  1. After 23 factorial optimization of a celecoxib topical emulgel, formulation F6 released 93.2% cumulatively over 36 hours and delivered 75.6% across porcine skin

    Using celecoxib as the model drug, this study applied a 23 factorial design to vary gelling agent type (Carbopol 934 vs. HPMC), liquid paraffin concentration (5.0% vs. 7.5% w/w), and emulsifier blend concentration (Tween 20/Span 20 at 1.5% vs. 2.5% w/w), prepared and characterized eight batches (F1–F8) of topical emulgel, and identified F6 (2.5% HPMC, 5% liquid paraffin, 2.5% surfactant) as optimal, with 93.2±1.2% cumulative in vitro release over 36 hours versus 45% for the standard formulation, release kinetics best fitted by the Higuchi diffusion model (R2=0.996), ex-vivo porcine skin cumulative transdermal delivery of 75.6±1.9% (4267±107 μg/cm2) with cutaneous retention of 12.8±1.

You’re all caught up